In this interview, Germano Tarantino, Science Director of Pharma NutraSpA, told NewsMed: long-COVID (also known as Chronic COVID Syndrome).
First, please tell us a little about Chronic COVID Syndrome (also called Long-COVID) and its symptoms.
Long COVID is a syndrome characterized by long-term SARS-CoV-2 infection symptoms that lasts for at least 4 weeks after the onset of symptoms.In fact, even if most people affected by COVID-19 fully recover within a few weeks, others will continue to experience symptoms after a few weeks or months.
Common signs and symptoms that persist over time include fatigue, dyspnea, joint pain, chest pain, cough, memory, concentration or sleep problems, anxiety or depression.
So are there any signs of factors / causes of chronic COVID syndrome, such as the age and severity of the original COVID infection?
Chronic fatigue is primarily a persistent symptom in both patients who have experienced a severe infection and those who have had a mild infection. Some studies have reported that women are most likely to be susceptible to symptoms for the next few months. A study led by the University of Glasgow concludes that seven months after seeking medical assistance for Covid-19, women under the age of 50 are seven times more tired and twice more tired than men.
In general, what are the benefits of amino acids and plant extracts in terms of improving human health and malaise?
Amino acid supplementation has been shown to not only stimulate the immune system, but also improve physical endurance and promote recovery from fatigue. Plant extracts contain a huge family of components that have a variety of effects on the human body. Some of them affect energy metabolism and mental fatigue. Several studies have shown, for example, the activity of Panax ginseng against chronic fatigue and its positive effects on the memory of healthy volunteers. Similar effects have shown that Eleuthero coccussenticosus promotes recovery from physical fatigue.
What is the target dietary supplement, Apportal®, and its role in improving fatigue and quality of life for people suffering from chronic COVID syndrome?
Apportal® is a unique dietary supplement based on a specific formulation of 19 nutrients, developed to achieve four key actions: antioxidants, immunomodulation, anti-asthenia, and energy metabolism promoters. .. In people suffering from Chronic Covid Syndrome, all these effects first reduce fatigue, improve general well-being and quality of life, and at the same time effectively contribute to promoting normal immune function.
What were some of the challenges you faced during the development of Apportal®, and how were they overcome?
The main issue was the technical issue. Our purpose as a company is always to provide people with products that overcome the limits of tolerance, absorbency and stability. In Apportal®, the combination of minerals, amino acids, plant extracts and vitamins can become unstable over time, intensifying competition for intestinal absorption among some nutrients.Succeeded in applying the patented Sucrosomial® Technology to avoid the above restrictions. The product was excellent in terms of stability, tolerance and proper absorption of each nutrient, while at the same time achieving excellent solubility (half a glass of water) and taste.
Also, what are the results surrounding the study conducted on post-COVID patients suffering from fatigue who received the dietary supplement Apportal®?
This study shows that Apportal® can reduce chronic fatigue in subjects after SARS-CoV-2 negative and improve quality of life and health through the synergistic effects of its ingredients. This represents an opportunity and possible solution for physicians and healthcare professionals to accelerate the recovery of fatigued subjects after chronic pancovid.
Are there any types of individuals who have proven that Apportal® is more effective? How did this affect recovery time?
Apportal® appears to work in almost all subjects (90.05%), regardless of gender, age, or severity of infection.
How important is further research / research to raise awareness of Longcovid and enhance the role that dietary supplements play in recovery?
This is very important.There is a need for evidence to show Effectiveness Dietary supplements (or inefficiencies). In fact, in this pandemic, we read a lot of news that one or more nutrients can help the pandemic, but no research has been published on the finished product or a single nutrient. You need to show which nutrient combinations and which doses are useful. This is demonstrated in Apportal® and is the first important step before exposing information to consumers.
Where can readers find more information?
About PharmaNutra SpA
Founded and led by President Andrea Lacorte and Vice President Roberto Lacorte, Pharma Nutra was founded in 2003. We develop unique dietary supplements and innovative medical devices to process the entire manufacturing process from unique raw materials to finished products. The effectiveness of the product is documented by considerable scientific evidence, including 140 publications. The Group sells and sells products in Italy and abroad. In Italy, products are sold through a network of 150 medical representatives servicing doctors, and Pharma Nutra products are exclusively sold to pharmacies throughout Italy. The products are sold in more than 50 countries abroad through 39 partners selected from the best pharmaceutical companies. PharmaNutra is a market leader in the manufacture of iron-based dietary supplements under the SiderAL® brand and boasts a number of important patents on Sucrosomial® technology. Over the years, the Group has developed accurate strategies for the management and production of intellectual property based on the integrated management of all of its various elements, including its own raw materials, patents, brands and clinical evidence.
About Germano Tarantino
Germano Tarantino graduated from Veterinary Medicine at the University of Pisa in 2003. After conducting extensive research in the field of human clinical nutrition, he was the director of science for the company. Since 2011, he has been the company’s chief scientific officer.
Germano Tarantino is researching and inventing penile solutions for humans.
Let’s talk about long COVID (chronic COVID syndrome)
Source link Let’s talk about long COVID (chronic COVID syndrome)